Financials

Discussions Technicals Seasonals

Diluted net income available to common stockholders of DIAGONAL BIO AB

Annual data

2021

2022

2023

TTM

‪‪−18.00 M‬‬

‪‪−13.50 M‬‬

‪‪−9.00 M‬‬

‪‪−4.50 M‬‬

‪0.00‬

Period

Value

Change

Change %

TTM

—

—

—

2023

‪‪−11.68 M‬‬

+‪‪4.49 M‬‬

+‪27.75‬%

2022

‪‪−16.16 M‬‬

‪‪−4.50 M‬‬

‪−38.59‬%

2021

‪‪−11.66 M‬‬

‪‪−11.08 M‬‬

‪‪−1.90 K‬‬%

Quarterly data

Q2 '20

Q3 '20

Q1 '21

Q2 '21

Q3 '21

Q4 '21

Q1 '22

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

‪‪−4.40 M‬‬

‪‪−3.30 M‬‬

‪‪−2.20 M‬‬

‪‪−1.10 M‬‬

‪0.00‬

Period

Value

Change

Change %

Q3 '24

‪‪−1.24 M‬‬

+‪‪2.20 M‬‬

+‪63.92‬%

Q2 '24

‪‪−3.44 M‬‬

—

—

Q1 '24

—

—

—

Q4 '23

‪‪−2.53 M‬‬

+‪‪127.00 K‬‬

+‪4.78‬%

Q3 '23

‪‪−2.66 M‬‬

+‪‪141.00 K‬‬

+‪5.04‬%

Q2 '23

‪‪−2.80 M‬‬

+‪‪894.00 K‬‬

+‪24.21‬%

Q1 '23

‪‪−3.69 M‬‬

+‪‪495.00 K‬‬

+‪11.82‬%

Q4 '22

‪‪−4.19 M‬‬

‪‪−431.00 K‬‬

‪−11.47‬%

Q3 '22

Q2 '22

Q1 '22

Q4 '21

Q3 '21

Q2 '21

Q1 '21

Q3 '20

Q2 '20